Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Zelinka

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Casopis Lekaru Ceskych|July 5, 2003
[The most common forms of endocrine-based hypertension]T Zelinka, J Widimský
Physiological Research|April 13, 2001
Twenty-Four hour blood pressure profile in subjects with different subtypes of primary aldosteronismT Zelinka, J Widimský
Casopis Lekaru Ceskych|February 5, 1993
[Does a hypertensive reaction to dynamic exercise imply an increased risk of developing essential hypertension?]T Zelinka, J Hradec, J Hampl
Physiological Research|February 7, 2002
Diminished circadian blood pressure rhythm in patients with asymptomatic normotensive pheochromocytomaT Zelinka, J Widimský, J Weisserová
Stress (Amsterdam, Netherlands)|May 22, 2007
Pheochromocytoma as a catecholamine producing tumor: implications for clinical practiceT Zelinka, G Eisenhofer, K Pacak
Casopis Lekaru Ceskych|March 8, 1991
[Significance of coronarography for therapeutic strategy in patients with ischemic heart disease]J Hradec, T Zelinka, M Aschermann
Journal of Human Hypertension|January 20, 2004
Diurnal blood pressure variation in pheochromocytoma, primary aldosteronism and Cushing's syndromeT Zelinka, B Strauch, L Pecen, et al.
Physiological Research|June 9, 2014
HIF signaling pathway in pheochromocytoma and other neuroendocrine tumorsI Jochmanová, T Zelinka, J Widimský, et al.
Journal of Human Hypertension|May 21, 2003
Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe regionB Strauch, T Zelinka, M Hampf, et al.
Physiological Research|March 16, 2013
Pheochromocytoma and markers of oxidative stressH Turková, O Petrák, J Skrha, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Casopis Lekaru Ceskych|July 5, 2003
[The most common forms of endocrine-based hypertension]T Zelinka, J Widimský
Physiological Research|April 13, 2001
Twenty-Four hour blood pressure profile in subjects with different subtypes of primary aldosteronismT Zelinka, J Widimský
Casopis Lekaru Ceskych|February 5, 1993
[Does a hypertensive reaction to dynamic exercise imply an increased risk of developing essential hypertension?]T Zelinka, J Hradec, J Hampl
Physiological Research|February 7, 2002
Diminished circadian blood pressure rhythm in patients with asymptomatic normotensive pheochromocytomaT Zelinka, J Widimský, J Weisserová
Stress (Amsterdam, Netherlands)|May 22, 2007
Pheochromocytoma as a catecholamine producing tumor: implications for clinical practiceT Zelinka, G Eisenhofer, K Pacak
Casopis Lekaru Ceskych|March 8, 1991
[Significance of coronarography for therapeutic strategy in patients with ischemic heart disease]J Hradec, T Zelinka, M Aschermann
Journal of Human Hypertension|January 20, 2004
Diurnal blood pressure variation in pheochromocytoma, primary aldosteronism and Cushing's syndromeT Zelinka, B Strauch, L Pecen, et al.
Physiological Research|June 9, 2014
HIF signaling pathway in pheochromocytoma and other neuroendocrine tumorsI Jochmanová, T Zelinka, J Widimský, et al.
Journal of Human Hypertension|May 21, 2003
Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe regionB Strauch, T Zelinka, M Hampf, et al.
Physiological Research|March 16, 2013
Pheochromocytoma and markers of oxidative stressH Turková, O Petrák, J Skrha, et al.
Pageof 4